Trial
NCT02042027
Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
—
Condition
Corneal Neovascularization
Intervention
Gamunex-C
Why stopped
No participants enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-05